- Home
- CRK vs ZLAB Comparison
CRK vs ZLAB Comparison
Compare CRK & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRK
- ZLAB
- Stock Information
- Founded
- CRK 1983
- ZLAB 2013
- Country
- CRK United States
- ZLAB China
- Employees
- CRK N/A
- ZLAB N/A
- Industry
- CRK Oil & Gas Production
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- CRK Energy
- ZLAB Health Care
- Exchange
- CRK Nasdaq
- ZLAB Nasdaq
- Market Cap
- CRK 4.7B
- ZLAB 4.0B
- IPO Year
- CRK N/A
- ZLAB 2017
- Fundamental
- Price
- CRK $15.91
- ZLAB $30.76
- Analyst Decision
- CRK Hold
- ZLAB Buy
- Analyst Count
- CRK 10
- ZLAB 6
- Target Price
- CRK $19.70
- ZLAB $57.22
- AVG Volume (30 Days)
- CRK 2.1M
- ZLAB 511.6K
- Earning Date
- CRK 10-29-2025
- ZLAB 08-07-2025
- Dividend Yield
- CRK N/A
- ZLAB N/A
- EPS Growth
- CRK N/A
- ZLAB N/A
- EPS
- CRK N/A
- ZLAB N/A
- Revenue
- CRK $1,654,969,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- CRK $52.18
- ZLAB $42.62
- Revenue Next Year
- CRK $17.23
- ZLAB $55.12
- P/E Ratio
- CRK N/A
- ZLAB N/A
- Revenue Growth
- CRK 20.80
- ZLAB 32.56
- 52 Week Low
- CRK $9.09
- ZLAB $19.16
- 52 Week High
- CRK $31.17
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- CRK 39.23
- ZLAB 37.68
- Support Level
- CRK $15.55
- ZLAB $28.71
- Resistance Level
- CRK $16.63
- ZLAB $33.97
- Average True Range (ATR)
- CRK 0.59
- ZLAB 1.17
- MACD
- CRK 0.32
- ZLAB -0.39
- Stochastic Oscillator
- CRK 63.38
- ZLAB 25.43
About CRK Comstock Resources Inc.
Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. Its oil and gas operations are concentrated in Louisiana and Texas.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.